Literature DB >> 31228536

MRI features of demyelinating disease associated with anti-MOG antibodies in adults.

Marc Denève1, Damien Biotti2, Sofia Patsoura3, Marine Ferrier3, Zuzana Meluchova3, Laurence Mahieu4, Françoise Heran5, Catherine Vignal6, Romain Deschamps7, Olivier Gout7, Nicolas Menjot de Champfleur8, Xavier Ayrignac9, Clarisse Carra Dallière9, Pierre Labauge9, Cécile Dulau10, Thomas Tourdias11, Hervé Dumas3, Christophe Cognard3, David Brassat2, Fabrice Bonneville12.   

Abstract

The spectrum of Myelin Oligodendrocytes Glycoprotein (MOG) antibody disease constitutes a recently described challenging entity, referring to a relatively new spectrum of autoimmune disorders with antibodies against MOG predominantly involving the optic nerve and spinal cord. The purpose of this article is to describe MRI features of MOG-AD involvement in the optic nerves, spinal cord and the brain of adults.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AQP4-IgG; MOG-AD; MOG-IgG; MRI; NMOSD; Neuromyelitis Optica

Mesh:

Substances:

Year:  2019        PMID: 31228536     DOI: 10.1016/j.neurad.2019.06.001

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  17 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Spinal Dural Arteriovenous Fistula: A Mimic of Demyelinating Disease and Radiculopathy.

Authors:  María Alfaro-Olivera; Ricardo D Otiniano-Sifuentes; Lourdes Simbrón-Ribbeck; Laura Zelada-Ríos; Danny Barrientos-Imán; Carlos Abanto; Jorge Ramírez-Quiñones; Ana Valencia
Journal:  Cureus       Date:  2022-04-14

3.  Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies.

Authors:  Patrick Murtagh; Amy Coman; Kirk Stephenson; Maria Gaughan; David Ryan; Graeme McNeill; Christopher McGuigan; Lorraine Cassidy
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

4.  Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON.

Authors:  Hao Kang; Huaiyu Qiu; Xiaofeng Hu; Shihui Wei; Yong Tao
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-09

5.  Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort.

Authors:  Giovanna S Manzano; Rebecca Salky; Farrah J Mateen; Eric C Klawiter; Tanuja Chitnis; Michael Levy; Marcelo Matiello
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

6.  Case Report: Post-Chikungunya-Associated Myeloneuropathy.

Authors:  Ameya Patwardhan; Atchayaram Nalini; Priyanka Priyadarshini Baishya; Karthik Kulanthaivelu; Haripriya Krishnareddy; Debayan Dutta; Tanushree Chawla; Ravindranadh Mundlamuri Chowdary; Ravi Yadav; Seena Vengalil
Journal:  Am J Trop Med Hyg       Date:  2021-08-23       Impact factor: 3.707

7.  MOG antibody-associated disease presenting with tumefactive lesions and closed-ring enhancement.

Authors:  Yin-Xi Zhang; Yang Zheng; Meng-Ting Cai; Qiang Du; Mei-Ping Ding
Journal:  Acta Neurol Belg       Date:  2021-05-25       Impact factor: 2.396

8.  Bilateral Meningo-Cortical Involvement in Anti-myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders: A Case Report.

Authors:  Guozhong Ma; Jinzhao He; Yan Li; Yan Xu; Yunxin Hu; Fang Cui
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

Review 9.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

Review 10.  State-of-the-Art Review: Demyelinating Diseases in Indonesia.

Authors:  Hana Larassati; Riwanti Estiasari; Reyhan E Yunus; Paul M Parizel
Journal:  Mult Scler Int       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.